Ticker >

Aristo Bio-Tech&Lis share price

Aristo Bio-Tech and Lifescience Ltd.

NSE: ARISTO SECTOR: Pesticides & Agrochemicals  7786   10   1

103.50
+14.35 (16.10%)
NSE: 24 Jul 03:32 PM

Price Summary

Today's High

₹ 105

Today's Low

₹ 96.95

52 Week High

₹ 124.7

52 Week Low

₹ 53.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

70.46 Cr.

Enterprise Value

91.1 Cr.

No. of Shares

0.68 Cr.

P/E

18.09

P/B

2.1

Face Value

₹ 10

Div. Yield

0.45 %

Book Value (TTM)

₹  49.37

CASH

1.85 Cr.

DEBT

22.49 Cr.

Promoter Holding

73.37 %

EPS (TTM)

₹  5.72

Sales Growth

31.36%

ROE

15.82 %

ROCE

16.11%

Profit Growth

148.44 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year31.36%
3 Year2.67%
5 YearNA

Profit Growth

1 Year148.44%
3 Year52.35%
5 YearNA

ROE%

1 Year15.82%
3 Year11.45%
5 Year13.58%

ROCE %

1 Year16.11%
3 Year12.94%
5 Year15.47%

Debt/Equity

0.7458

Price to Cash Flow

-25.31

Interest Cover Ratio

2.72114476647055

CFO/PAT (5 Yr. Avg.)

1.59823969961847

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 73.37 0
Sep 2023 73.37 0
Mar 2023 73.37 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company’s PEG ratio is 0.219790764301411.
  • The company has an efficient Cash Conversion Cycle of 36.201263849588 days.
  • The company has a high promoter holding of 73.37%.

 Limitations

  • The company has shown a poor revenue growth of 2.6650031380262% for the Past 3 years.
  • Company has negative cash flow from operations of -2.7836.
  • The company has a low EBITDA margin of 2.83033952110617% over the past 5 years.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 201.67 201.23 167.22 165.76 217.75
Total Expenditure 194.85 196.72 162.87 160.59 209.05
Operating Profit 6.82 4.51 4.34 5.17 8.7
Other Income 0.11 0.01 0.22 0.27 0.33
Interest 2.25 2.6 2.31 2.36 2.75
Depreciation 0.51 0.52 0.75 1.1 1.54
Exceptional Items -0.07 0 0 0 0
Profit Before Tax 4.1 1.4 1.5 1.98 4.74
Tax 1.27 0.39 0.42 0.55 1.18
Net Profit 2.83 1.01 1.08 1.43 3.56
Adjusted EPS (Rs.) 5.66 2.02 2.15 2.87 5.23

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 5 5 5 5 6.81
Total Reserves 6.3 7.31 8.39 9.87 23.35
Borrowings 7.2 10.67 12.06 11.09 10.17
Other N/C liabilities -0.06 -0.07 0 0.11 0.01
Current liabilities 72.14 64.88 55.97 50.94 59.49
Total Liabilities 90.58 87.78 81.42 77 99.82
Assets
Net Block 7.91 8.26 12.31 14.36 15.62
Capital WIP 1.48 2.82 0 0.1 1.1
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.49 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 80.69 76.7 69.1 62.54 83.1
Total Assets 90.58 87.78 81.42 77 99.82
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 4.17 1.4 1.5 1.98 4.74
Adjustment 2.56 3.49 3.22 3.44 4.23
Changes in Assets & Liabilities 2.66 -3.07 -2.09 1.71 -10.58
Tax Paid -1.24 -0.41 -0.34 -0.35 -1.26
Operating Cash Flow 8.15 1.41 2.28 6.78 -2.78
Investing Cash Flow -2.44 -2.19 -1.98 -3.16 -3.75
Financing Cash Flow -5.77 0.87 -0.72 -3.31 7.97
Net Cash Flow -0.06 0.09 -0.41 0.3 1.44

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Sep 2023% Mar 2024%
promoters 73.37 73.37 73.37
himanshu barhat 7.56 7.56 7.56
ketankumar harkantbhai jo... 10.58 10.58 10.58
kusum barhat - 9.18 9.18
n s barhat huf 3.67 3.67 3.67
narendra singh barhat 33.49 33.49 33.49
neeta k joshi 7.05 7.05 7.05
richa n barhat 1.84 1.84 1.84
kusum narendra singh barh... 9.18 - -
PARTICULARS Mar 2023% Sep 2023% Mar 2024%
investors 26.63 26.63 26.63
llp - 0.28 0.05
anant aggarwal 4.09 2.28 -
sonia - 1.32 -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Aristo Bio-Tech&Lis Stock Price Analysis and Quick Research Report. Is Aristo Bio-Tech&Lis an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Aristo Bio-Tech&Lis stock price today is Rs 103.5. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Aristo Bio-Tech&Lis . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Aristo Bio-Tech&Lis has a PE ratio of 18.0855525267352 which is high and comparatively overvalued .

  • Share Price: - The current share price of Aristo Bio-Tech&Lis is Rs 103.5. One can use valuation calculators of ticker to know if Aristo Bio-Tech&Lis share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Aristo Bio-Tech&Lis has ROA of 4.02911841685575 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Aristo Bio-Tech&Lis has a Current ratio of 1.39705373083143 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Aristo Bio-Tech&Lis has a ROE of 15.8245800302525 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Aristo Bio-Tech&Lis has a Debt to Equity ratio of 0.7458 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Aristo Bio-Tech&Lis has reported revenue growth of 31.3633580372036 % which is fair in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Aristo Bio-Tech&Lis for the current financial year is 3.99600463829346 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Aristo Bio-Tech&Lis is Rs 0.25 and the yield is 0.4487 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Aristo Bio-Tech&Lis is Rs 5.7228 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Aristo Bio-Tech&Lis in Ticker for free. Also, one can get the intrinsic value of Aristo Bio-Tech&Lis by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Aristo Bio-Tech&Lis
X